Critical Decision Points for Augmenting Interpersonal Psychotherapy for Depressed Adolescents: A Pilot Sequential Multiple Assignment Randomized Trial.
Critical Decision Points for Augmenting Interpersonal Psychotherapy for Depressed Adolescents: A Pilot Sequential Multiple Assignment Randomized Trial.
复制标题
DOI:
10.1016/j.jaac.2018.06.032
复制
发表时间:
2019-01
影响因子:
13.3
通讯作者:
Vock D
中科院分区:
文献类型:
--
作者:
Gunlicks-Stoessel M;Mufson L;Bernstein G;Westervelt A;Reigstad K;Klimes-Dougan B;Cullen K;Murray A;Vock D
Practice parameters recommend systematic assessment of depression symptoms over the course of treatment to inform treatment planning; however, there are currently no guidelines regarding how to use symptom monitoring to guide treatment decisions for psychotherapy. The current study compared two time points (week 4 and week 8) for assessing symptoms during interpersonal psychotherapy for depressed adolescents (IPT-A) and explored four algorithms that use the symptom assessments to select the subsequent treatment. Forty adolescents (aged 12–17 years) with a depression diagnosis began IPT-A with an initial treatment plan of 12 sessions delivered over 16 weeks. Adolescents were randomized to a week 4 or week 8 decision point for considering a change in treatment. Insufficient responders at either time point were randomized a second time to increased frequency of IPT-A (twice per week) or addition of fluoxetine. Measures were administered at baseline and weeks 4, 8, 12, and 16. The week 4 decision point for assessing response and implementing treatment augmentation for insufficient responders was more efficacious for reducing depression symptoms than the week 8 decision point. There were significant differences between algorithms in depression and psychosocial functioning outcomes. Therapists implementing IPT-A should routinely monitor depression symptoms and consider augmenting treatment for insufficient responders as early as week 4 of treatment. An Adaptive Treatment Strategy for Adolescent Depression. https://clinicaltrials.gov; NCT02017535.
登录
查看更多内容
影响因子:
7.4
作者:
Gunlicks-Stoessel, Meredith;Mufson, Laura
通讯作者:
Mufson, Laura
影响因子:
3.7
作者:
LEWINSOHN, PM;CLARKE, GN;ANDREWS, J
通讯作者:
ANDREWS, J
DOI:
10.1191/1740774s04cn002oa
发表时间:
2004-02-01
期刊:
Clinical trials (London, England)
影响因子:
--
作者:
Lavori, Philip W;Dawson, Ree
通讯作者:
Dawson, Ree
影响因子:
--
作者:
DeRubeis, RJ;Hollon, SD;Gallop, R
通讯作者:
Gallop, R
DOI:
10.1097/01.chi.0000240838.78984.e2
发表时间:
2006-12-01
影响因子:
13.3
作者:
Curry, John;Rohde, Paul;March, John
通讯作者:
March, John